Christina S. Chu, MD
Christina S. Chu, MD
Associate Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania
Department: Obstetrics and Gynecology
Contact information
Jordan Center for Gynecologic Oncology, 3West Pavilion
Perelman Center for Advanced Medicine at Penn
34th & Civic Center Blvd
Philadelphia, PA 19104
Perelman Center for Advanced Medicine at Penn
34th & Civic Center Blvd
Philadelphia, PA 19104
Office: 215 662 3318
Fax: 215 349 5680
Fax: 215 349 5680
Email:
cchu@uphs.upenn.edu
cchu@uphs.upenn.edu
Education:
B.A. (Applied Mathematics)
Northwestern University, Evanston IL, 1990.
M.D.
University of Pennsylvania School of Medicine, Philadelphia, PA, 1995.
Permanent linkB.A. (Applied Mathematics)
Northwestern University, Evanston IL, 1990.
M.D.
University of Pennsylvania School of Medicine, Philadelphia, PA, 1995.
Description of Research Expertise
Immunotherapy of ovarian cancerDescription of Clinical Expertise
Multimodality managment of gynecologic cancersSelected Publications
Borofsky Samuel E, Levine Marc S, Rubesin Stephen E, Tanyi Janos L, Chu Christina S, Lev-Toaff Anna S: Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients. Abdominal imaging May 2012.Chu Christina S, Boyer Jean, Schullery Daniel S, Gimotty Phyllis A, Gamerman Victoria, Bender James, Levine Bruce L, Coukos George, Rubin Stephen C, Morgan Mark A, Vonderheide Robert H, June Carl H: Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer immunology, immunotherapy : CII 61(5): 629-41, May 2012.
Tanyi Janos L, Marsh Evelyn B, Dalmau Josep, Chu Christina S: Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms. Acta obstetricia et gynecologica Scandinavica 91(5): 630-4, May 2012.
Jean S, Tanyi J L, Montone K, McGrath C, Lage-Alvarez M Martinez, Chu C S: Papillary thyroid cancer arising in struma ovarii. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 32(3): 222-6, Apr 2012.
Hagemann Ian S, Hagemann Andrea R, LiVolsi Virginia A, Montone Kathleen T, Chu Christina S: Risk of occult malignancy in morcellated hysterectomy: a case series. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 30(5): 476-83, Sep 2011.
Hagemann Andrea R, Hagemann Ian S, Cadungog Mark, Hwang Wei-Ting, Patel Priya, Lal Priti, Hammond Rachel, Gimotty Phyllis A, Chu Christina S, Rubin Steven C, Birrer Michael J, Powell Daniel J, Feldman Michael D, Coukos George: Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer biology & therapy 12(4): 367-77, Aug 2011.
Hagemann Andrea R, Cadungog Mark, Hagemann Ian S, Hammond Rachel, Adams Sarah F, Chu Christina S, Rubin Steven C, Zhang Lin, Addya Kathakali, Birrer Michael J, Gimotty Phyllis A, Coukos George: Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment. Cancer biology & therapy 12(4): 357-66, Aug 2011.
Tanyi JL, McCann G, Hagemann AR, Coukos G, Rubin SC, Liao JB, Chu CS: Clinical predictors of bevacizumab-associated gastrointestinal perforation. Gynecol Oncol 120: 464-469, 2011.
Katz E, Dugan NL, Cohn JC, Chu C, Smith RG, Schmitz KH : Weight lifting in patients with lower extremity lymphedema secondary to cancer: a pilot and feasibility study. Arch Phys Med Rehabil 91(7):1070-76, 2010.
Braly P, Nicodemus CF, Chu C, Collins Y, Edwards R, Gordon A, McGuire W, Schoonmaker C, Whiteside T, Smith LM, Method M: The immune adjuvant properties of front-line carboplatin-paxlitaxel: A randomized phase II study of alternative schedules of intravenous oregovomab-chemo-immunotherapy in advanced ovarian cancer. J Immunother 32:54-65, 2009.